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Abstract
Chronic kidney disease (CKD), which leads tocortical bone loss and increasedporosity,increases therisk of fracture. Animal
models have confirmed that these changes compromise whole bone mechanical properties. Estimates from whole bone
testing suggest that material properties are negatively affected, though tissue-level assessmentshavenot been conducted.
Therefore, the goal of the present study was to examine changes in cortical bone at different length scales using a rat model
with theprogressive development of CKD. At 30 weeks of age (,75% reduction in kidney function), skeletally mature male
Cy/+ rats were compared to their normal littermates. Cortical bone material propertieswere assessed with reference point
indentation (RPI), atomic force microscopy (AFM), Raman spectroscopy,and high performance liquid chromatography
(HPLC). Bones from animals with CKD had higher (+18%) indentation distance increase and first cycle energy dissipation (+
8%) as measured by RPI.AFM indentation revealed a broader distribution of elastic modulus values in CKD animals witha
greater proportion of both higher and lower modulus values compared to normal controls. Yet, tissue composition,
collagen morphology, and collagen cross-linking fail to account for these differences. Though the specific skeletal tissue
alterations responsible for these mechanical differences remain unclear, these results indicate that cortical bone material
properties are altered in these animals and may contribute to the increased fracture risk associated with CKD.
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Introduction
Chronic kidney disease—mineral and bone disorder (CKD-
MBD) is characterized by hyperphosphatemia, secondary hyper-
parathyroidism, and an increased risk offractures[1–3].Unlike
osteoporosis, CKD-MBD appears to have a preferential impact on
cortical bone, leading to reduced bone mass and increased
porosity [4–6].These effects likely underlie the increased fracture
risk observed in patients with CKD[7–9].
Whole bone (structural)mechanical properties are dependent
upon a number of variables [10–11]. While bone mass is a major
determinant, both the distribution of bone and its material
properties (inherent physical and chemical properties) also play
crucial roles. Most biomechanical studies in rodent models of
CKD have focused on structural mechanical properties, employ-
ing three-point bending or dynamic mechanical analysis (DMA)
[12–18]. These studies indicate that the bending and viscoelastic
properties of bone are compromised in animals with CKD.
Specifically, DMA indicates that diseased animals have lower
storage modulus (a measure of stiffness) and tan delta (a measure of
energy dissipation) [14–15], while three point bending studies
indicate that ultimate load, stiffness, and energy to failure are
lower in CKD animals [12].
While there is an increasing awareness of the importance of
bone quality in CKD [19], few studies have explicitly examined
material properties in animal models[14–15,20]. Material prop-
erties can be estimated from whole bone mechanical tests using
standardengineering equations that account for whole bone
structure and geometry.Because these estimates assume that
skeletal tissue is homogeneous, isotropic, and linearly elastic,
direct measures ofmaterial properties in bone would provide
additionalinsight into how the disease is affecting fracture
resistance. Therefore, the goal of the present study was to examine
material-level changes in cortical bone at several length scales
using a rat model with the progressive development of CKD.
Specifically, we hypothesized that CKD adversely impacts cortical
bone material properties as determined by material-level mechan-
ical testing and assessments of bone composition and collagen
morphology.
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Materials And Methods
Animal Model
The current study utilized a slowly progressive animal model of
CKD, the Cy/+ rat. Cy/+ ratsare characterized by autosomal
dominant polycystic kidney disease [21]. These animals have a
mutation (R823W) in Anks6, a gene that codes for the protein
SamCystin. Currently, the function of this protein is unknown,
and the specific role of this mutation in the development of
polycystic kidney disease is unclear. Aside from its expression in
the kidney, however, little is known about its role in the cell
[22].Unlike most other PKD-related proteins, though, SamCystin
does not localize to the primary cilia of kidney cells [23]. While
there is no known human disease associated with this gene,
thespontaneous onset of disease provides a helpful phenotypic
model of human CKD [21].Unlike the more common surgical
models[24], Cy/+ rats display a gradual onset of disease.And
unlike most genetic models[25–26], they exhibit a slow enough
progression that bone disease does not begin to occur until after
skeletal maturity.
Skeletal tissuefrom animals in a previous study wasutilized [12].
All animals were fed a casein diet (Purina AIN-76A; 0.7% Pi) to
increase phosphorus availability in order to produce a more
consistent kidney disease phenotype.Fresh frozen tibiaefrom 30-
week-old male Cy/+ ratsand their age-matched non-affected
littermates were assessed mechanically, compositionally, and
morphologically at several length scales.Fresh frozen femora were
used for collagen cross-linking analyses. Blood was collected at the
end of the experiment for biochemical analyses (previously
reported in [12]).All procedures were conducted under the
approval of Indiana University School of Medicine Institutional
Animal Care and Use Committeeprotocol # 10479.
Reference Point Indentation
Tibiae were thawed to room temperature and soaked overnight
in phosphate-buffered saline. The anteromedial surface of the
proximal diaphysis of the tibia was assessed using reference point
indentation (RPI) (Biodent Hfc, Active Life Scientific, Santa
Barbara, CA). The reference probe, which housed a BP2 test
probe, waslowered vertically, normal to the surface, until itrested
on the surface of the bone.In order to stabilize the unit, a reference
force of ,13 N was applied before each measurement was
initiated.Each test included a series of 10 cycles at 2 Hz to a force
of 10 N. Bones were maintained in a hydrated state throughout
the test. Five locations per sample, each ,2 mm apart, were
indented. Raw data from the RPI analysis software (version 2.0)
were imported into a customized MATLAB code (Mathworks)
designed to provide cycle-by-cycle data for each test [27], from
which first cycle unloading slope, indentation distance increase,
first cycle energy dissipation, creep indentation distance, first cycle
indentation distance, total indentation distance, and total energy
dissipation were calculated for each test. All five tests from each
animal were averaged to produce a single value for each variable.
Tissue Composition
Raman spectroscopy was performed using a LabRAM HR 800
Raman Spectrometer (HORIBA JobinYvon, Edison, NJ) con-
nected to a BX41 microscope (Olympus, Tokyo, Japan). A
660 nm laser was focused on the bone surface using a 50X
objective to a spot size of ,10 mm. Five locations were imaged
,1 mm apart on the anteromedialmid-diaphysiswith five 20
second acquisitions at each location as previously published [28].
A five point linear baseline correction was applied in LabSpec 5
(HORIBA JobinYvon). Using OriginPro 8.6 (OriginLab, North-
ampton, MA), a single Gaussian peak was fit to the PO4
3-n1 peak,
and the areas under the PO4
3-n1, CO3
2-n1, and Amide I peaks
were calculated at each location. Type B carbonate substitution
was found by the band area ratio of CO3
2-n1/PO4
3-n1. The
degree of matrix mineralization was determined by the band area
ratios of PO4
3-n1/Amide I. Mineral maturity (crystallinity) was
determined by the inverse of the full width at half maximum
(FWHM) of the PO4
3-n1 peak.
AFM Indentation
The anteromedial portion of the mid-diaphysis used above was
polished with a 3 mm polycrystalline water-based diamond
suspension in order to create a flat region for testing. Nanoinden-
tation was performed using a BioScope Catalyst atomic force
microscope (Bruker, Santa Barbara, CA), operating in peak force
tapping mode using previously published methods [29]. Indenta-
tions were performed using a polycrystalline diamond probe
(NaDia ND-DYC series; Advanced Diamond Technologies, Inc.)
with a measured spring constant of 29.25 N/m. Four locations per
sample were indented and, at each location (20 mm620 mm grid),
49 indentationswere performed. Samples were loaded to 200 nN
with force-separation curves acquired from each indentation.
Within each location, indentations were spaced about 2 mm apart
in order to avoid interactions from neighboring indentations. In
total, 196 indentations were performed for each sample. The
indentation elastic modulus was calculated from 5% to 95% of the
withdrawal curve using the classic Hertz model of contact between
a rigid sphere and an elastic half space because the indentation
depth is much smaller than the radius of curvature of the probe
[29]. The indentation elastic modulus was determined from the
following equation: E= 3F(1-v‘2)/(4r‘(1/2) d‘(3/2)) where E is the
indentation elastic modulus, F is the indentation force, v is the
Poisson’s ratio of the sample (assumed to be 0.35), r is the tip
radius (nominal radius of 50 nm, with the same probe used for all
samples), and d is the indentation depth. All of the individual
indentations were averaged to produce a single value for each
animal, though individual tests were used for distribution
comparisons among the groups.
Collagen Morphology
Following AFMindentation, the polished surface was partially
decalcified by soaking the bones in 0.5 M EDTA for 25 minutes
followed by five minutes of sonication in a water bath. This process
was repeated five times for each sample. For imaging, RTESPA
probes were used (Bruker; radius nominally 8 nm, spring constant
= 40 N/m). The scan size was set at 3.5 mm with 5126512 pixels
and a scan rate of 0.5 lines/s. For measurements of collagen
morphology, four locations were imaged per sample, and 10 to 15
fibrils were measured at each location. 40 to 50 fibrils per sample
were averaged to produce a single value for each animal, though
the individual tests were used for distribution comparisons. Using
SPIP 5.1.10 (Image Metrology, Hrsholm, Denmark),D-periodic
spacing was calculated using2D Fast Fourier Transformations (2D
FFTs) as previously described [28].
Collagen Cross-Linking
Segments of bone (,3 mm in length) from the proximal femoral
diaphysis were fully demineralized in 20% EDTA (0.68 M,
pH 7.4). Approximately 10 mg of demineralized bonewerehydro-
lyzedin6 N HCl (,10 mL per 1 mg) at 110uC for 20 to 24 hours.
After evaporating the acidusing a SpeedVAC centrifuge with
coldtrap, each hydrolysate was resuspended in ultrapure water,
split into two equal portions, and dried. Half the residue was
resuspended in ultrapure water with an internal standard
Cortical Material Properties in CKD
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(561026 g/L pyridoxine). The solution was filtered and diluted
with 0.05% heptafluorobutyric acid in 10% acetonitrile, and
50 mL of each hydrolysate were assayed by a high performance
liquid chromatography (HPLC) system (Beckman-Coulter System
Gold 168) with a silica-based column (Waters Spherisorb).
Standards with varying concentrations of pyridinoline (Pyd)
(Quidel),deoxypyridinoline (Dpd) (Quidel),pentosidine(PE) (Inter-
national Maillard Reaction Society), and a constant amount of
pyridoxinewere also assayed. Using a Waters 2475 fluorescence
detector (excitation/emission of295/400 nm for Pyd and Dpd and
328/378 nm for PE), chromatograms were recorded to determine
the amount of each crosslink. These amounts were then
normalized by collagen content, which was determined from the
other half of each hydrolysate by another HPLC assay [30].
Briefly, witha-amino-butyric acid (a-ABA) included as an internal
standard, the amino acids were subjected to derivatization
withphenyl isothiocyanate (PITC). Along with standards of
varying concentrations of hydroxyproline (Sigma) and proline
(Sigma)and a constant amount of a-ABA, the derivatized samples
were resuspendedin a buffer solution of 5% acetonitrile in 5 mM
disodium phosphate. Upon injecting 50 mLof this sample,
chromatograms were generated with a UV detector (Beckman-
Coulter System Gold 168). The calculated mass of hydroxyproline
was then multiplied by 7.5 (assuming 13–14% of type I collagen by
mass) and divided by the molecular weight of collagen (30,000 Da)
[31], thereby giving crosslink concentration as mol/mol of
collagen.
Statistical Analysis
All analyses were performed using SPSS software. Comparisons
between groups were made with Student’s t-tests (assumptions
validated by Shapiro-Wilk and Levene tests). When non-normal
distributions or unequal variances were present, comparisons were
made using Wilcoxon ranked-sum tests and unequal variance t-
tests, respectively. Distributions included all measures from each
individual, and comparisons were made using Kolmogorov-
Smirnov tests. A priori a-levels were set at 0.05 to determine
significance.
Results
Animal Model
Details about the phenotype of these animals have been
previous published [12]. Briefly, measures of kidney function,
including BUN (+116%) and the albumin-to-creatinine ratio (+
301%), weresignificantly higher in Cy/+ animals compared to the
normal controls. Similar to what is observed in humans with
CKD, there were no differences between groups for phosphorus or
calcium levels, but both serum PTH (+240%) and FGF23 (+195%)
weredrastically higher(FIGURE 1).Cy/+ animals had higher
numbers of osteoclasts and higher levels of bone remodeling.
Using three-point bending, they exhibited lower ultimate load (2
28%), stiffness(217%), and energy to fracture (246%). Estimates
of material properties indicate that they had lower ultimate stress
(220%) and toughness (247%) (FIGURE 2)[12].
Reference Point Indentation
Indentation distance increase (IDI)provides an assessment of the
change in depth between the first cycle and the final cycle. Cy/+
animals had significantly higher IDI (+18%), indicating that the
tissue ismore prone to damage under the same applied load
(FIGURE 3). The amount of energy dissipated during the first
cycle was also significantlyhigher in animals with CKD (+8%).
While the first cycle creep indentation distance (+18%) was higher
in Cy/+ animals, there was no difference in microstructural
stiffness (first cycle unloading slope)between the two groups.No
differences were noted in first cycle indentation distance, total
indentation distance, or total energy dissipation (Table 1).
AFM-based indentation
There was no difference in the indentation elastic modulus
between the groups (FIGURE 4a). However, when all indenta-
tions within each groupwere considered as a population, the
distribution of elastic modulus values did differ between the two
groups. Animals with CKD had a greater proportion of both high
and low values of elastic modulus than their normal counterparts
(FIGURE 4b).
Tissue Composition
Raman spectroscopy revealed no differences between animals
with CKD and their normal counterparts with regard to overall
compositionof the mineral and organic matrices (Table 2).
Specifically, there were no differences between the groups in the
phosphate-to-amide I ratio (the mineral-to-matrix ratio), mineral
crystallinity, or the carbonate-to-phosphate ratio (a reflection of
type B carbonate substitution).
Collagen Morphology and Cross-Linking
There were no mean differences in D-periodicity between the
two groups (Table 2). There were also no differences in the
distribution of D-periodicity when all fibrils were considered. In
addition, both enzymatic and non-enzymatic cross-linksas assessed
by HPLC were similar between groups (Table 2).
Discussion
The mechanical integrity of skeletal tissue is determined by the
amount of tissue present, its distribution, and its quality.
Compromises in any of these factors can lead to an increased
fracture risk. The notable loss of cortical bone mass associated with
CKD is assumed to be primarily responsible for the increased
fracture risk seen in patients [5]. The current study advances our
understanding of bone fragility in CKD by showing that
microscale and nanoscale mechanical properties are alteredinde-
pendently of changes in bone mass and porosity.
Our lab has previously documented reductions in both
structural and estimated materialproperties in Cy/+ rats, animals
with progressive CKD [12,32]. But, whole bone testing only
provides indirect estimates of material properties, which is why
wedirectly assessedmicroscale mechanical propertiesusing refer-
ence point indentation (RPI).RPI data from the present study
indicate that animals with CKD had higher IDI, higher first cycle
creep indentation distance, and first cycle energy dissipation.
Taken together, these results indicatethat the tissue in animals with
CKD is less resistant to indentation and more prone to damage.
Indentation distance increase was nearly 20% higher in CKD
animals compared to their normal counterparts. Similar differ-
ences in IDI have been previously reported in diabetic rats[33].
These data have two important implications. First, they show that
CKD negatively affects skeletal tissue independently of bone mass,
which means that estimates of bone massalone likely underesti-
mate the overall mechanical effects of CKD.These differences in
bone quality may explain the conflicting data available on BMD
and fracture risk in CKD patients[6,34–40]. Second, our data
provide a basis for considering in vivo applications of RPI in the
clinical setting of CKD. RPI has been used to successfully
differentiate patients with and without hip fractures[41] as well as
those with and without atypical femoral fractures [42]. A related
Cortical Material Properties in CKD
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indentation device has also been shown to discriminate patients
with diabetes from their normal counterparts[43]. Assessment of
tissue-level mechanical properties, combined with standard
imaging modalities to measure bone mass, cortical geometry
(especially porosity), and trabecular architecture, may prove to be
an ideal combination by which to assess the overall mechanical
integrity of bones in patients with CKD.
The current study also employed a hierarchical approach by
examining nanoscale mechanical properties with atomic force
microscopy. AFM indentation provides a direct assessment of the
nanoscale stiffness produced by the collagen and mineral
composite. Consistent with measurements of microscale stiffness
(first cycle unloading slope), these results show that the average
indentation elastic modulus was not significantly different between
the two groups.Yet, the distribution of elastic modulus values was
different. Animals with CKD displayed a greater degree of
heterogeneity in nanoscale elasticity. Because increased material
heterogeneity is often considered advantageous [44], these results
may reflect an adaptive response to declining integrity at larger
length scales. Alternatively, extreme variations in nanoscale
properties maylead to localized stress concentrations that result
in damage accumulation from lower forces[45]. Although
heterogeneity is likely necessary for normal mechanical integrity,
extreme heterogeneity may be problematic from a mechanical
Figure 1. Biochemical assessment of kidney function and mineral metabolism. These previously published data (Allen et al., 2013) show
abnormalities in kidney function and mineral metabolism resulting from hyperparathyroidism in the animals utilized in the current work. Data are
presented as a percentage of non-affected normal animals with (*) representing statistical significance.
doi:10.1371/journal.pone.0099262.g001
Figure 2. Structural mechanical properties and estimated material properties. These previously published data (Allen et al., 2013) show
compromised whole bone mechanical properties from femoral 3-point bending and apparent material-level mechanical properties derived from
standard beam bending equations in the animals utilized in the current work. Data are presented as a percentage of non-affected normal animals
with (*) representing statistical significance.
doi:10.1371/journal.pone.0099262.g002
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standpoint [46]. Future studies should attempt to better under-
stand the role of material heterogeneity in CKD in order to
specifythe contributionofmicroscale and nanoscalepropertiesto
whole bone mechanical properties.
While whole bone, microscale, and nanoscale mechanical
differences are present in animals with CKD, tissue composition,
collagen morphology, and collagen cross-linking fail to account for
the differences. These data conflict with studiesshowing higher
mineral-to-matrix ratios, lower mineral crystallinity, increased
advanced glycationendproducts (AGEs), and decreased gene
expression of lysyl oxidase in alternative models of CKD [14–
15,47]. One potential explanation for these disparate results is that
these previous studies utilized younger animals that developed
advanced CKD during skeletal growth. Teasing apart the
interaction between growth and disease is difficult, which is why
the present study employed the use of a model in which kidney
disease occurs after skeletal maturity.
Previous studies have demonstrated that non-enzymatic cross-
links (pentosidine, specifically) are increased in the circulation of
patients with CKD[48–51]. These findings coincide with the
accumulation of AGEs in soft tissues detected by fluorescence
methods[52]. Because high levels in the circulation are associated
with the deposition of AGEs in other tissues, this may be true of
skeletal tissue as well. To date, this has only been confirmed in one
small clinical study in patients on dialysis [53]. Currently, there are
few data in animal models, and clinical trials examining predialysis
patients are lacking. Using a low turnover 5/6 nephrectomy
model, two studies have reported increased pentosidineusing
Figure 3. Microindentation reveals that CKD skeletal tissue is less able to resist damage. Using reference point indentation (RPI), the
indentation distance increase (IDI) was found to be significantly higher in CKD animals compared to normal. These data indicate that the mechanical
integrity of the bone is less able to resist microscale damage formation and propagation. Data are presented as mean and standard deviation. *p,
0.05 versus normal controls.
doi:10.1371/journal.pone.0099262.g003
Table 1. Mechanical properties from microindentation and nanoindentation.
RPI Normal (n =6) Cy/+ (n = 6) p-values
First Cycle Indentation Distance (mm) 83.3863.15 88.2465.45 *0.088
First cycle Energy Dissipation (mJ) 275.53614.00 297.94619.35 *0.044
First Cycle Unloading Slope (N/mm) 0.4760.02 0.4560.03 *0.113
First Cycle Creep Indentation Distance (mm) 6.0860.43 7.1760.95 *0.028
Indentation Distance Increase (mm) 10.8160.92 12.7161.13 *0.009
Total Indentation Distance (mm) 89.3962.73 95.2165.13 #0.080
Total Energy Dissipation (mJ) 663.06643.53 712.30689.19 *0.252
AFM Normal (n =5) Cy/+ (n = 4) p-values
Indentation Elastic Modulus (MPa) 962.99 345.98 996.73 588.99 0.920
Values are presented as mean 6 standard deviation.
*equal variance t-test.
#Wilcoxon ranked-sum test.
p-values less than 0.05 are in bold.
doi:10.1371/journal.pone.0099262.t001
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Raman spectroscopy[14–15]. While Raman spectroscopy has
been utilized to detect AGEs in ocular tissue[54], its ability to
detect changes in bone is unknown as HPLC is the standard
method used to measure AGEs in skeletal tissue[53,55–58]. Here,
having employed HPLC, thehypothesized increases in AGE
content were not observed. While increases may occur with more
advanced disease in theseanimals, the relationship between
circulating pentosidineand its accumulation in bone collagen in
CKDremains unresolved.
At present, clinical data on bone quality in CKD are minimal.
Aside from the aforementioned dialysis study [53], CKD patients
with high bone turnover had reduced stiffness and a decreased
mineral-to-matrix ratio as assessed on iliac crest biopsies [59]. As
these data are from cancellous bone, though, direct comparison
with the current work on cortical bone is difficult. Connecting
these dots by examining cortical bone properties in patients (which
is possible with iliac crest biopsies) and cancellous properties in rats
will be an essential step in moving forward.
Limitations to the current study should also be recognized. First,
because tissue from a previous study was used, the sample sizes
used here were small. Hence, any applications to other animal
models or patients should occur with a measure of caution.
Second, the mechanical assessments were localized to the
periosteal surface, which may not be fully representative of the
entire cortex. As such, the assessed parameters may differ at other
cortical sites. Finally, this study assessed material properties in 30-
week-old animals. As the disease progresses, differences in
composition and morphologymay arise.Nevertheless, the advan-
Figure 4. Nanoindenation reveals that CKD skeletal tissue has increased heterogeneity in the elastic modulus compared to normal
bone. There was no significant difference in the average elastic modulus (A), but the distribution of elastic modulus values was significantly broader
(B), with a greater proportion of both high and low values in CKD relative to normal (p,0.0001).
doi:10.1371/journal.pone.0099262.g004
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tage of using 30-week-old animals is that these animals are
skeletally mature but do not yet exhibit the rampant increase in
cortical porosity present at 35 weeks [32].
In conclusion, these data show that both microscale and
nanoscale cortical bone material properties are altered in an
animal model of CKD. The specific skeletal tissue alterations
responsible for these mechanical differences remain unclear.
Nevertheless, in addition to bone loss and cortical porosity, defects
in material-level mechanical properties may also contribute to the
increased fracture risk associated with CKD.
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